The present invention relates to the compound ((2R,2R)-bis(((tetrahydro-2H-pyran-4- carbonyl)oxy)methyl) 1,1- adipoylbis(pyrrolidine-2-carboxylate), pharmaceutical compositions comprising the same and the use of the same for treatment of diseases or disorders wherein depletion of serum amyloid P component (SAP) would be beneficial, including amyloidosis, Alzheimer s disease, type 2 diabetes mellitus and osteoarthritis.